Model
Edge
Alnylam Pharmaceuticals, Inc.
0001829252
Filing type
144
Filing date
Feb 26, 2026
Updated
Feb 27, 2026 ยท 2:05 PM
Copy reference
Filing
144
Notice of Proposed Sale of Securities